Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility：a Meta-analysis;Patatin 样磷酯酶结构域蛋白 3 基因 rs738409 位点多态性与非酒精性脂肪肝易感性关系的 Meta 分析

Chinese Journal of Endemiology

Volumn 36, Issue 1, 2015, Pages 78-82

  Wu, Pengbo ^a   Shu, Yongxiang ^a   Guo, Fang ^a   Luo, Hesheng ^a   Guo, Zhang ^b   Tan, Shiyun ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b People s Hospital of Guangxi Zhuang Autonomous Region   (United States)

Author keywords

Gene polymorphism; Meta analysis; Non alcoholic fatty liver; Patatin like phospholipase domain containing protein 3; Susceptibility

Indexed keywords

PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; PHOSPHOLIPASE; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ARTICLE; DISEASE PREDISPOSITION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; NONALCOHOLIC FATTY LIVER; SENSITIVITY ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CAUCASIAN; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; HUMAN;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPASE; MEMBRANE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHOSPHOLIPASES; POLYMORPHISM, GENETIC;

EID: 84929515461     PISSN: 10004955     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0254-6450.2015.01.018     Document Type: Article

References (35)

1. ［1］Adams LA，Angulo P. Recent concepts in non-alcoholic fatty liver disease［J］. Diabet Med，2005，22：1129-1133.
2. ［2］McCullough AJ. The clinical features，diagnosis and natural history of nonalcoholic fatty liver disease［J］. Clin Liver Dis，2004，8：521-533.
3. ［3］Fan JG，Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China［J］. J Hepatol，2009，50：204-210.
4. ［4］Little J，Higgins JP，Ioannidis JP，et al. Strengthening the reporting of genetic association studies（STREGA）：an extension of the STROBE statement ［J］. Eur J Epidemiol，2009，24（1）：37-55.
5. ［5］Hotta K，Yoneda M，Hyogo H，et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease［J］. BMC Med Genet，2010，11：172.
6. ［6］Hyysalo J，Gopalacharyulu P，Bian H，et al. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity［J］. Diabetes，2014，63（1）：312-322.
7. ［7］Kantartzis K，Peter A，Machicao F，et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene［J］. Diabetes，2009，58 （11）：2616-2623.
8. ［8］Kawaguchi T，Sumida Y，Umemura A，et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese［J］. PLoS One，2012，7（6）：e38322.
9. ［9］Kolesnikova O，Nemtsova V. P408 Effects of PNPLA3 polymorphisms on the progression of non-alcoholic fatty liver disease ［J］. J Hepatol，2014，60 Suppl 1：S204.
10. ［10］Krawczyk M，Grunhage F，Zimmer V，et al. Variant adiponutrin （PNPLA3）represents a common fibrosis risk gene：non-invasive elastography-based study in chronic liver disease［J］. J Hepatol，2011，55（2）：299-306.
11. ［11］Li Y，Xing C，Tian Z，et al. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population［J］. BMC Med Genet，2012，13：113.
12. ［12］Lin YC，Chang PF，Hu FC，et al. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children［J］. J Pediatr，2011，158（5）：740-744.
13. ［13］Liu YL，Patman GL，Leathart JB，et al. Carriage of the PNPLA3 rs738409 C＞G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma［J］. J Hepatol，2014，61（1）：75-81.
14. ［14］Niu TH，Jiang M，Xin YN，et al. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population［J］. World J Gastroenterol，2014，20（13）：3655-3662.
15. ［15］Peng XE，Wu YL，Lin SW，et al. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a han Chinese population［J］. PLoS One，2012，7（11）：e50256.
16. ［16］Rametta R，Ruscica M，Dongiovanni P，et al. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance［J］. Eur J Clin Invest，2014，44（7）：627-633.
17. ［17］Ravikanth VV，Mitnala S，Avanthi US，et al. PNPLA3 gene polymorphism but not APOC3 enhances risk for nonalcoholic fatty liver disease in Indian subjects［J］. J Clin Exp Hepatol，2013，3 Suppl 1：S24.
18. ［18］Romeo S，Sentinelli F，Cambuli VM，et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life［J］. J Hepatol，2010，53（2）：335-338.
19. ［19］Rotman Y，Koh C，Zmuda JM，et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3（PNPLA3）with histological severity of nonalcoholic fatty liver disease［J］. Hepatology，2010，52（3）：894-903.
20. ［20］Sookoian S，Castano GO，Burgueno AL，et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity［J］. J Lipid Res，2009，50 （10）：2111-2116.
21. ［21］Speliotes EK，Butler JL，Palmer CD，et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease［J］. Hepatology，2010，52（3）：904-912.
22. ［22］Valenti L，Alisi A，Galmozzi E，et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease［J］. Hepatology，2010，52（4）：1274-1280.
23. ［23］Valenti L，Al-Serri A，Daly AK，et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease［J］. Hepatology，2010，51（4）：1209-1217.
24. ［24］Valenti L，Rametta R，Ruscica M，et al. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls［J］. BMC Gastroenterol，2012，12：111.
25. ［25］Wagenknecht LE，Palmer ND，Bowden DW，et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort：the insulin resistance atherosclerosis family study［J］. Liver Int，2011，31（3）：412-416.
26. ［26］Wang CW，Lin HY，Shin SJ，et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population ［J］. Liver Int，2011，31（9）：1326-1331.
27. ［27］Xu J，Xin YN，Lyu WH，et al. Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease［J］. Chin J Hepatol，2013，21（8）：619-623.（in Chinese）徐静，辛永宁，吕维红，等. PNPLA3 rs738409 基因多态性与非酒精性脂肪性肝病遗传易感性的关系［J］. 中华肝脏病杂志，2013，21（8）：619-623.
28. ［28］Zain SM，Mohamed R，Mahadeva S，et al. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease［J］. Hum Genet，2012，131 （7）：1145-1152.
29. ［29］Bhatt SP，Nigam P，Misra A，et al. Genetic variation in the patatin-like phospholipase domain-containing protein-3 （PNPLA-3）gene in Asian Indians with nonalcoholic fatty liver disease［J］. Metab Syndr Relat Disord，2013，11（5）：329-335.
30. ［30］Corbin KD，Abdelmalek MF，Spencer MD，et al. Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis［J］. FASEB J，2013，27（4）：1674-1689.
31. ［31］Goran MI，Walker R，Le KA，et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents ［J］. Diabetes，2010，59（12）：3127-3130.
32. ［32］Gorden A，Yang R，Yerges-Armstrong LM，et al. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity［J］. Hum Hered，2013，75（1）：34-43.
33. ［33］Baulande S，Lasnier F，Lucas M，et al. Adiponutrin，transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage［J］. J Biol Chem，2001，276：33336-33344.
34. ［34］Jenkins CM，Mancuso DJ，Yan W，et al. Identification，cloning，expression，and purifi cation of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities［J］. J Biol Chem，2004，279：48968-48975.
35. ［35］Yuan X，Waterworth D，Perry G，et al. Population-based genomewidc association studies reveal six loci influencing plasma levels of liver enzynles［J］. Am J Hum Genet，2008，83：520-528.